How much weight loss was achieved in studies
PubMed-cited research with dosages
Infections: vulvovaginal candidiasis, bacterial vaginosis, vulvovaginitis Comparative observational signal (protective association): In a phenome-wide association study comparing people with type 2 diabetes prescribed GLP-1 receptor agonists vs SGLT2 inhibitors and DPP4 inhibitors (NIH All of Us cohort, Jan 2018Oct 2023), semaglutide prescription was associated with reduced risk of diagnoses including candidiasis of vulva and vagina and inflammatory disease of cervix, vagina, and vulva compared with SGLT2 inhibitors
Semaglutide is a glucagon-like peptide-1 receptor agonist that was originally designed for diabetes management but has shown powerful benefits for weight management
Semaglutide sodium is a research product that breaks down into semaglutide base and is available to purchase online, sold as "not for human use." It isn't quite the same thing as semaglutide, since it hasn't received the same FDA testing and approval, Blakeney said